About this event

  • Date and time Wed 6 Feb 2019 from 9:00am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Gastroenterology and Hepatology

Hear internationally acknowledged leaders address best practice and controversies and challenges in the management of benign and malignant disease of the pancreas.  

This area of medicine often presents the most complex and challenging cases that any medical professional can be confronted with, gastroenterologist, general surgeon, clinical oncologist, medical oncologist or HPB surgeon, specialist nurse practitioners and consultant nurses.

This symposium will provide a comprehensive update and forum for clinicians from a variety of specialties including gastroenterology, general surgery and oncology, to meet and discuss the major controversies in pancreatic disease.

Topics include:

  • Comparing novel advances in early diagnosis of pancreatic cancer  
  • ​Understand the challenges and limitations in surgery for pancreatic cancer  
  • ​​Review existing best practice and innovative approaches to treating pancreatic cancer and improving survival  
  • ​​Be aware of current understanding in systemic IgG4 disease  
  • ​How to apply imaging modalities in the diagnosis and management of cystic masses of the pancreas  
  • ​​Understand the use of endotherapy for diseases of the pancreas  
  • ​​Be aware of the emerging understanding of the interrelationship between the microbiome and diseases of the pancreas 

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Dr Andrew Thillainayagam, Consultant Gastroenterologist and Hepatologist, Imperial College Healthcare NHS Trust and Council Member, Gastroenterology & Hepatology Section, Royal Society of Medicine

Towards earlier diagnosis in pancreatic cancer

Professor Stephen Pereira, Department of Gastroenterology and Hepatology, Institute of Digestive Health, University College London

Surgery for pancreatic cancer: Are we doing enough?

Professor Long Jiao, Hepatopancreaticobiliary Surgery Unit, Imperial College Healthcare NHS Trust

Questions and answers
Tea and coffee break
Novel therapies in pancreatic cancer

Mr Satvinder Mudan, Consultant General and Oncology Surgeon, The London Clinic

Systemic IgG4 disease and the pancreas

Dr George Webster, Consultant Physician, Clinical Lead for Hepato-biliary Medicine, Department of Gastroenterology and Hepatology, University College London

Questions and answers
Lunch
Cystic Neoplasms of the Pancreas

Dr Paul Tait, Consultant Radiologist, Hammersmith Hospital

Endotherapy in pancreatic disease

Dr Christopher Wadsworth, Consultant Physician, Imperial College Healthcare NHS Trust

Questions and answers
Tea and coffee break
The microbiome and the pancreas

Professor Julian Marchesi, Professor of Digestive Health, Faculty of Medicine, Imperial College London

Questions and answers
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Other events of interest

EPM02 Promo

Public Health Registrar symposium - Adapting to a changing world

This training day is aimed at Specialty Registrars (SpRs) in Public Health from across the country, offering a unique opportunity for trainees to learn from other regions and network.

  • Price £27 - £75
  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
GHM04 Promo
Sold Out

Health research in conflict and complex environments

Examine health research in conflict and other complex environments and discuss the state of the field and challenges for the future.

  • Price £36 - £100
  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom